These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


641 related items for PubMed ID: 9390594

  • 1. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
    Stevens JB, Walker SC, Fontenot JP.
    Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
    [Abstract] [Full Text] [Related]

  • 2. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion.
    Mellinghoff H, Radbruch L, Diefenbach C, Buzello W.
    Anesth Analg; 1996 Nov; 83(5):1072-5. PubMed ID: 8895288
    [Abstract] [Full Text] [Related]

  • 3. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
    Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, Severinsen IK, Bülow K.
    J Clin Anesth; 1995 Dec; 7(8):635-9. PubMed ID: 8747561
    [Abstract] [Full Text] [Related]

  • 4. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M, Riad W.
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [Abstract] [Full Text] [Related]

  • 5. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
    Kim KS, Chun YS, Chon SU, Suh JK.
    Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
    [Abstract] [Full Text] [Related]

  • 6. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.
    Smith CE, Donati F, Bevan DR.
    Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium.
    Carroll MT, Mirakhur RK, Lowry D, Glover P, Kerr CJ.
    Anaesthesia; 1998 Aug; 53(8):744-8. PubMed ID: 9797517
    [Abstract] [Full Text] [Related]

  • 8. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
    Carroll MT, Mirakhur RK, Lowry DW, McCourt KC, Kerr C.
    Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?
    Baurain MJ, Hoton F, D'Hollander AA, Cantraine FR.
    Br J Anaesth; 1996 Oct; 77(4):496-9. PubMed ID: 8942335
    [Abstract] [Full Text] [Related]

  • 11. A two-center study evaluating the hemodynamic and pharmacodynamic effects of cisatracurium and vecuronium in patients undergoing coronary artery bypass surgery.
    Searle NR, Thomson I, Dupont C, Cannon JE, Roy M, Rosenbloom M, Gagnon L, Carrier M.
    J Cardiothorac Vasc Anesth; 1999 Feb; 13(1):20-5. PubMed ID: 10069278
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
    Prielipp RC, Coursin DB, Scuderi PE, Bowton DL, Ford SR, Cardenas VJ, Vender J, Howard D, Casale EJ, Murray MJ.
    Anesth Analg; 1995 Jul; 81(1):3-12. PubMed ID: 7598277
    [Abstract] [Full Text] [Related]

  • 13. [Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial].
    Barrio J, San Miguel G, García V, Pelegrín F.
    Rev Esp Anestesiol Reanim; 2007 Jul; 54(7):399-404. PubMed ID: 17953333
    [Abstract] [Full Text] [Related]

  • 14. Neuromuscular effects of vecuronium and neostigmine in Montreal and Paris.
    Salib Y, Frossard J, Plaud B, Debaene B, Meistelman C, Donati F.
    Can J Anaesth; 1994 Oct; 41(10):908-12. PubMed ID: 8001209
    [Abstract] [Full Text] [Related]

  • 15. Assessment of neuromuscular and haemodynamic effects of cisatracurium and vecuronium under sevoflurane-remifentanil anaesthesia in elderly patients.
    Keleş GT, Yentür A, Cavuş Z, Sakarya M.
    Eur J Anaesthesiol; 2004 Nov; 21(11):877-81. PubMed ID: 15717704
    [Abstract] [Full Text] [Related]

  • 16. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA, Mastronardi P, Hunter JM, Gomar C, Mirakhur RK, Aguilera L, Giunta FG, Meistelman C, Prins ME.
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [Abstract] [Full Text] [Related]

  • 17. [Priming technique with cisatracurium Onset time at the laryngeal muscles].
    Schmidt J, Albrecht S, Petterich N, Fechner J, Klein P, Irouschek A.
    Anaesthesist; 2007 Oct; 56(10):992-1000. PubMed ID: 17598079
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
    Naguib M, Abdulatif M, al-Ghamdi A.
    Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
    [Abstract] [Full Text] [Related]

  • 20. Neuromuscular blocking effects of cisatracurium and its antagonism with neostigmine in a canine model of autosomal-recessive centronuclear myopathy.
    Martin-Flores M, Paré MD, Campoy L, Gleed RD.
    Br J Anaesth; 2015 Dec; 115(6):927-31. PubMed ID: 26582854
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.